Correlation Between BridgeBio Pharma and BioatlaInc
Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma and BioatlaInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma and BioatlaInc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BridgeBio Pharma and BioatlaInc, you can compare the effects of market volatilities on BridgeBio Pharma and BioatlaInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma with a short position of BioatlaInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma and BioatlaInc.
Diversification Opportunities for BridgeBio Pharma and BioatlaInc
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BridgeBio and BioatlaInc is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and BioatlaInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioatlaInc and BridgeBio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma are associated (or correlated) with BioatlaInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioatlaInc has no effect on the direction of BridgeBio Pharma i.e., BridgeBio Pharma and BioatlaInc go up and down completely randomly.
Pair Corralation between BridgeBio Pharma and BioatlaInc
Given the investment horizon of 90 days BridgeBio Pharma is expected to under-perform the BioatlaInc. But the stock apears to be less risky and, when comparing its historical volatility, BridgeBio Pharma is 2.09 times less risky than BioatlaInc. The stock trades about -0.02 of its potential returns per unit of risk. The BioatlaInc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 279.00 in BioatlaInc on January 23, 2024 and sell it today you would lose (61.00) from holding BioatlaInc or give up 21.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BridgeBio Pharma vs. BioatlaInc
Performance |
Timeline |
BridgeBio Pharma |
BioatlaInc |
BridgeBio Pharma and BioatlaInc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BridgeBio Pharma and BioatlaInc
The main advantage of trading using opposite BridgeBio Pharma and BioatlaInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma position performs unexpectedly, BioatlaInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioatlaInc will offset losses from the drop in BioatlaInc's long position.BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
BioatlaInc vs. Pmv PharmaceuticalsInc | BioatlaInc vs. C4 TherapeuticsInc | BioatlaInc vs. Nautilus Biotechnology | BioatlaInc vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |